Panacea Biotec Limited has received a Letter of Award from UNICEF for supply of 115 million doses of its bivalent oral polio vaccine (bOPV) worth ~US$ 14.95 million (~Rs.127 Crore) in CY2025.

Such a contract symbolizes Panacea Biotec's continued commitment toward global health by contributing its share of the fight ...

As per the company's filing, the United Nations International Children's Emergency Fund (UNICEF) awarded the company to ...

Panacea Biotec's shares rose 5% as the company received a Letter of Award from UNICEF for supplying 115 million doses of its ...

Panacea Biotec hit an upper circuit of 5% at Rs 455.70 after the company received a letter of award (LoA) from the United Nations International Children's Emergency Fund (UNICEF) for supply its ...

Following a UNICEF order worth ₹127 crore, Panacea Biotec shares increased 5% to ₹456.25. The stock has seen substantial ...

Shares of Panacea Biotec are now locked in an upper circuit of 5% at ₹454.90. With today's surge, the stock has rallied over ...

India's benchmark indexes ended little changed on Thursday amid a lack of major triggers and thin trading as the year-end ...

The Nifty Bank index fell 85 points to 51,233, and the Midcap index dropped 35 points to 57,058. Metal stocks, which had ...

PM Shehbaz emphasises importance of increasing use of technology across all health sectors, including polio eradication, to ...

A total of 272 million doses of polio vaccines bOPV donated by Indonesia to Myanmar arrived at Yangon International Airport on Friday the state- ...

The share touched a 52-week high of Rs 489.00 and a 52-week low of Rs 112.70 on 12 December, 2024 and 04 June, 2024, respectively. Currently, the stock is trading 11.13 percent below its 52-week high ...